Effect of reserpine and other drugs on the monoamine metabolism with special reference to the CNS.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D004790:Enzyme Induction / Q000187:drug effects; D006220:Haloperidol / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D051379:Mice; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism; D012110:Reserpine / Q000494:pharmacology*; D012701:Serotonin; D013268:Stimulation, Chemical; D009435:Synaptic Transmission / Q000187:drug effects*
D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D012110:Reserpine; D008238:Lysergic Acid Diethylamide; D008995:Monoamine Oxidase; D006220:Haloperidol; D001058:Apomorphine; D007099:Imipramine; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine